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The  cyclical  appearance  of  antibody-forming  cells  (AFC) 1  in  the  spleen  and 
peripheral blood following a single antigenic stimulus is a well-documented phenom- 
enon  (1).  Generally, within  the  2-wk period after an antigen  stimulus,  two peaks of 
AFC are observed. The first peak occurs at  ~4-6 d  and the second at  10-13 d  (1-8). 
Both T-independent  (2-4)  and T-dependent  antigens  (5-8)  are capable of inducing 
very similar cyclical AFC responses in a  wide variety of organisms. 
Various explanations for the cyclic production of AFC have been offered including: 
competition between free antibody and AFC precursors for persistent  antigen  (2,  6); 
sequential  expression  of various  classes  of antigen-specific  immunoglobulin  (5);  the 
release of antigen  by macrophages  (2);  regulation of AFC formation that is comple- 
ment dependent  (3); synchronous recruitment of memory B cells that is regulated by 
highly localized levels of specific antibody (7); and regulator T  cells  (8). 
Recently, results  from our laboratory have indicated  that  the cyclical appearance 
of splenic  plaque-forming  cells  (PFC)  may be  the  result  of cell-to-cell  interactions 
based  upon  idiotypic  recognition  (4).  We observed  a  cyclical production  of splenic 
PFC after a  single injection of heat-killed strain  R36a Streptococcus pneumoniae  (Pn)  in 
BALB/c mice.  Concurrent  with  the  anti-Pn  response  was  a  cyclical and  reciprocal 
expansion  (or activation)  of the  clone(s) recognizing the  dominant  idiotype  of the 
myeloma protein secreted by the TEPC-15 plasmacytoma (T-15) of the Pn-stimulated 
lymphocytes. 
As  both  T  and  B  cells  are  known  to  participate  in  anti-idiotypic  responses,  we 
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wished  to  functionally analyze the  role of the  two  cell populations in  terms  of the 
cyclical immune response. Thus, we studied both the idiotypic (antigen reactive) and 
anti-idiotypic immune responses in normal, athymic (nude), and thymus-grafted nude 
mice  after  a  single  antigenic  challenge  with  Pn.  We  could  compare,  by  utilizing 
normal and nude mice, the effects of direct antibody feedback mechanisms and those 
regulatory mechanisms requiring T  cells upon the cyclical course of both the idiotypic 
and anti-idiotypic immune response. 
This study demonstrates that both the cyclical idiotypic (antigen specific) and anti- 
idiotypic  immune  responses  are  thymus  dependent  in  BALB/c  mice.  Nude  mice 
(backcrossed onto the BALB/c genetic background)  respond with only a  single peak 
of anti-Pn PFC that is equal to the initial BALB/c response. In both groups of mice, 
the T-15 clone is dominant  and circulating anti-Pn antibody titers are similar. The 
reciprocal anti-idiotypic response does not occur  in  nude  mice but  thymic reconsti- 
tution of nude mice restores the cyclical idiotypic and anti-idiotypic responses. These 
results  support  the  concept  that  the  cyclical  immune  response  is  a  product  of 
regulatory interactions between  idiotypic and  anti-idiotypic lymphocyte clones and 
that  T  ceils are  required  for  the  cyclical  responses  after  immunization  with  a  T- 
independent antigen. 
Materials  and  Methods 
Animals.  BALB/c mice were purchased from Charles River Breeding Laboratories (Wil- 
mington, Mass.). Congenitally athymic, nude  (nu/nu)  mice with the BALB/c genetic back- 
ground and their phenotypically normal littermates (LM) (+/nu or +/+) were obtained either 
through a National Cancer Institute contract with Charles River Breeding Laboratories or were 
from  our own  colony  founded  from  mice provided by  Dr.  Norman  Reed,  Montana  State 
University, Bozeman, Mont. The latter are produced by heterozygous parents derived from the 
ninth  backcross on  the  BALB/c strain.  Only  mice  from  the same  source  were  used  in  an 
individual experiment (Charles River Breeding Laboratories, exp. 1 and 2; and mice from our 
colony, exp. 3). 
Thymic  reconstitution  of nude  mice  was  accomplished by  implanting a  single neonatal 
BALB/c thymus beneath the capsule of each of the recipient's kidneys (thymus gland-reconsti- 
tuted nude [TG-nude] mice) as described by Dukor et al (9). All TG-nude mice were examined 
for evidence of a  successful thymic graft at the time of the PFC assay. TG-nude mice were 
rested at least 4 wk after thymic implantation and used within 6 wk post-implantation. All 
mice within a single experiment were age-matched to ~  +  3 wk. Mice of both sexes were used. 
Antigen and Immunizations.  Pn  was  grown  in  Todd-Hewitt  broth  and  harvested  during 
exponential growth according to the method of Liu and Gotschlich (I0). The recovered bacteria 
were washed  four times in  0.15  M  NaCI  (saline) and  lyophilized in  sterile vials (Wheaton 
Scientific Div., Wheaton Industries, Millville, N. J.; catalog No. 224822).  A bacterial vaccine 
was prepared by reconstituting the contents of a vial with sterile distilled water and heating the 
contents to 60°C for 45 min. No viable bacteria could be demonstrated after this treatment. 
The suspension was then adjusted to a concentration of 100 #g bacterial lyophylate/ml saline. 
This Pn vaccine was stored at 4°C for the duration of an experiment. 
The time-course of the idiotypic (T-15) and anti-idiotypic (anti-T-15) clonal responses after 
stimulation by Pn was visualized by the sequential immunization of groups (three to four) of 
mice. Daily, for 14 d, a group of mice was immunized by an intraperitoneal injection of 20 p.g 
of Pn vaccine. On the 15th d, all immunized mice and a control group of comparable (normal, 
nude,  or  TG-nude)  unimmunized  mice  were  killed and  their spleens  and  sera  assayed  as 
described below. Thus each group represented a unique stage of the anti-Pn response. 
Preparation of the Cell Wall Polysaccharide of S. pneumoniae (PnC)-coated Sheep Erythrocytes.  PnC 
was extracted according to the procedure of Liu and Gotschlich (10) with the exception that 
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ether extraction and dialysis against cold, distilled water. This dialyzate was lyophilized and 
stored at -20°C. 
Sheep erythrocytes  (SRBC),  (Colorado Serum Co.,  Denver, Colo.)  were coated  with  the 
recovered PnC by a  procedure similar to that  for  bacterial lipopolysaccharide described by 
M~iller (11). Briefly,  PnC was dissolved in saline to a  concentration of 0.1-0.2 mg/ml. This 
solution was heated in a boiling water bath for ~30 min, briefly cooled, and then added to 
packed, washed (three times in saline) SRBC at a ratio of 0.5 ml PnC solution:0.1 ml packed 
SRBC. The cells were then gently mixed with a Pasteur pipette and allowed to incubate with 
the PnC solution for 30 min at 37°C. The cells were washed twice in a large excess (20- to 50- 
fold) of saline and finally in Hanks' balanced salts solution (HBSS), pH 7.1. 
The  success  of  PnC  coating was  determined by  specific  hemagglutination (HA)  using 
clarified ascitic fluid from BALB/c mice bearing, intraperitoneally, the TEPC-15 plasmacy- 
toma.  The  ascitic fluid did not agglutinate normal SRBC  and  the  hemagglutination titer 
against PnC-coated SRBC (PnC-SRBC) was always ~ 1:100,000. 
Source  and  lodination  of  Myeloma Proteins.  The  TEPC-15,  MOPC-315,  and  McPC-603 
BALB/c plasmacytoma lines were obtained from Litton Bionetics (Kensington, Md.) under a 
National Cancer Institute contract. Each tumor was maintained by subcutaneous passage  in 
BALB/c mice. Ascites fluid containing the relevant myeloma protein was obtained by injecting 
mice intraperitoneally with 0.5 ml of mineral oil (Diamond Drug Incorporated, Westhaven, 
Conn.) at least  1 wk before an intraperitoneal inoculation of tumor cells. The resulting ascitic 
fluid was recovered, pooled, and clarified by centrifugation. The proteins contained in each 
ascitic fluid were twice precipitated by the addition of an equal volume of saturated (NH4)2SO4. 
This precipitate was  dissolved  in a  small amount of water and extensively dialyzed against 
borate-buffered (0.1 M) saline (BBS), pH 8.0. 
The dialyzate was then further purified by gel filtration on a Sephadex G-200 (Pharmacia 
Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.)  column equilibrated with BBS. 
The eluate was monitored for absorption at 280 nm and for the ability to agglutinate antigen- 
coated SRBC. A protein peak corresponding to the void volume of the Sephadex G-200 column 
also contained most of the HA activity. The recovered TEPC-15 (IgA, ~; anti-phosphorylcho- 
line) and McPC-603  (IgA,  ~;  anti-phosphorylcholine) myeloma proteins agglutinated PnC- 
SRBC  but  not trinitrophenyl (TNP)-substituted (TNP-SRBC)  (12) or normal SRBC.  The 
MOPC-315 myeloma protein (IgA, ~.z; anti-nitrophenyl) agglutinated only TNP-SRBC. The 
recovered purified myeloma proteins were concentrated to ~20 mg protein/ml BBS and stored 
at -60°C. 
Radio-iodination of purified myeloma proteins was  accomplished via the  N-hydroxysuc- 
cinimide  ester of mono-iodinated (lzsI)p-hydroxyphenylpropionic  acid (13), obtained from New 
England Nuclear (Boston, Mass.). Iodination  was carried out generally according to the method 
of Bolton and Hunter (14). Briefly, a volume (--<500/xl) of benzene containing = 1.0 mCi of 125I 
(-1,500 Ci/mmol) was transferred to a chilled (~5°C) vial and the benzene evaporated with 
a stream of dry N2 gas. The vial was then cooled to 0°C and 5 mg of myeloma protein added 
(10 mg/ml BBS). The reaction was allowed to continue for  1.5-2  h  at 0°C with continuous 
stirring. At this time, 0.5 ml of 0.2 M  glycine (in BBS) was added, destroying any unreacted 
iodination reagent. 
The iodinated myeloma proteins were separated from any contaminating glycine (and/or 
glycine conjugates) and 3-(4-hydroxyphenyl) propionic acid by gel filtration over Sephadex G- 
50. Columns were equilibrated with 0.05 M  phosphate buffer, pH 7.5, and = 10 mg of bovine 
serum albumin was washed through before the addition of the iodination reaction products. 
Two peaks  of radioactivity were recovered, the first  coinciding with the void volume of the 
column. This first  peak was dialyzed against continuously flowing phosphate-buffered saline 
for 48 h  at 4°C. The sp act of the recovered dialyzate was --~6-8 ×  104 cpm//~g protein and 
__.93% of this activity was precipitated by trichloroacetic acid. The ability of the radiolabeled 
myeloma proteins to hemagglutinate the appropriate antigen-coupled  SRBC was the equivalent 
of unlabeled proteins. 
Serum Antibody Assay.  Mice were killed by decapitation and ~0.4 ml of blood was collected 
from each mouse. The collected blood was allowed to clot overnight at 4°C. Serum was then 
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sample was tested for its capacity to agglutinate PnC-SRBC. The initial dilution of each serum 
was  1:4 and all titrations were  performed in duplicate, using microtiter plates (Cooke  Engi- 
neering Co., Alexandria, Va.). 
Preparation of Lymphocytes.  Immediately after blood collection, the spleen was removed into 
a dish containing ice-cold  HBSS. A suspension of splenocytes was then made by pressing the 
spleen through a stainless steel screen.  This suspension was transferred to a conical-bottomed 
tube. Cell clusters and noncellular  debris were removed by allowing the spleen cell suspensions 
to sediment briefly and then transferring the supernates to a second tube. These cell suspensions 
were then washed three times in cold HBSS containing 2% fetal calf serum (FCS)  (Microbio- 
logical Associates).  The washed cells were resuspended in 5 ml of HBSS containing 2% FCS, 
the numbers of viable lymphocytes/ml determined by trypan blue exclusion, and the volume 
of each cell suspension adjusted to a final concentration of 10  v viable lymphocytes/ml. 
PFC Assay.  Aliquots of these  suspensions were used to determine the numbers of anti-Pn 
PFC/106 splenocytes.  A modified hemolytic plaque assay in agarose (15) was employed utilizing 
PnC-SRBC  (4). The  background  of  anti-SRBC  PFC  (routinely ___5/106 splenocytes)  was 
determined and that number subtracted from the anti-PnC-SRBC PFC count. Each determi- 
nation was performed in duplicate. 
Idiotype-bindin~ Assay.  Cell-associated anti-idiotypic  activity was determined as the ability of 
an aliquot of 10  viable splenocytes to bind specifically the T- 15 idiotype. This was accomplished 
by incubating the cells with either the radiolabeled TEPC-15 or a control myeloma protein 
(McPC-603 or MOPC-315) and determining  the cell-bound activity. Specific T- 15 binding  was 
calculated as: 
T- 15 bound (percentage of control) 
=  (counts per minute T-15 immunized) -  (counts per minute M-603 immunized) 
×  I00. 
(counts per minute T-15 control) -  (counts per minute M-603 control) 
Specifically,  5/~g of radiolabeled myeloma protein (preliminary experiments indicated that 
1 /~g  of  either  TEPC-15  or  MOPC-315  saturated  the  binding capacity  of  106  BALB/c 
splenocytes [4]) was  added  to  duplicate tubes containing 106 splenocytes in ice-cold  HBSS 
containing 2% FCS. The tubes were incubated overnight at 4°C. The cells were then washed 
four times with cold HBSS containing 10%  FCS and the resultant cell  pellets counted in a 
Packard y-spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.).  The cpm/tube 
ranged from ~-5 ×  103 to 12 ×  103 cpm, representing ~60 ng of bound myeloma protein. The 
variation between duplicates was routinely ~12%. 
Only a single control (the idiotype of the myeloma protein secreted  by the MOPC-315 or the 
McPC-603 plasma cytoma)  idiotype was used in a  given experiment. Previous experiments 
demonstrated that either protein serves equally well as a control (4). 
Inhibition of PFC by Heterologous Anti-T-15  Serum.  Rabbit anti-T-15 serum was  raised  by 
injecting purified TEPC-15 myeloma protein into rabbits. The antiserum was rendered specific 
by absorption with pooled murine IgM and the purified MOPC-315 myeloma protein insolu- 
bilized onto Affi-gel  10  Sepharose beads  (Bio-Rad Laboratories, Richmond, Calif.)  and by 
incubation with normal C57BL/6 splenocytes (10V/ml antiserum). The addition of this antise- 
rum at a  1:500 final dilution inhibited by --85% the number of anti-Pn PFC produced by a 
representative pool of Pn-immunized BALB/c mice. The numbers of either C57BL/6 anti-Pn 
PFC or BALB/c anti-SRBC-PFC were not inhibited at the same concentration. 
Statistical Analyses.  In certain cases Student's t statistic (two-tailed) was employed to deter- 
mine if significant differences  (P _<0.05) existed between serial PFC values. 
Results 
The specificity of the labeled idiotype probes was determined by inhibition  studies 
utilizing unlabeled homologous or heterologous protein competitors (Fig. I). Addition 
of a  100-fold excess of unlabeled homologous protein resulted in a  >50% decrease in 
binding of the labeled idiotype. The same excess of heterologous protein resulted in 
only "'18% inhibition. GARNETT  KELSOE,  DALE  ISAAK,  AND JAN  CERNY 
o~ 
Yg 
Q 
I  I  I  1 
I  I0  I00  I,O00 
Myelomo  protein added 
90- 
o 
°>,-o  80- 
~.o  ~,0 
N_  r- 
-o'~  60 
e,"  50 
Fx6.  1.  Inhibition of binding of radiolabeled myeloma proteins on BALB/c spleen cells (10 s)  in 
the presence of increasing amounts of competing unlabeled homologous or heterologous myeloma 
proteins (abscissa). The amount  of cell-bound activity is expressed as the percent of that  in  the 
absence of any competitor. ]2~I-TEPC-15  (1 #g)  plus TEPC-15  (r-I) or plus MoPe-315  (O);  12~I- 
MoPe-315 (1/~g)  plus MOPC-315 (11) or plus TEPC-15 (O). 
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F]c.  2.  The kinetics of primary immune response of BALB/c mice to Pn: (a) specific anti-Pn PFC 
in the spleen; (b) relative changes in binding of 12SI-TEPC-15  by splenocytes. Each point represents 
the mean from a cohort of three to four mice, in three successive experiments (17, I, and A). 
The kinetics of both PnC-specific PFC production and relative T-15  binding by 
spleen cells from Pn-immunized BALB/c mice were determined in three successive 
experiments  (Fig.  2).  The  accumulation of specific PFC  after a  single injection of 
vaccine followed a cyclical pattern over a  14-d period; an initial relatively broad peak 
(=400 PFC/106 splenocytes) occurred on day 4-6 declining variably thereafter until 
a second sharper peak (= 150 PFC/106 splenocytes) appeared on day 12-13 (Fig. 2 a). 
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Fro. 3.  The kinetics of primary anti-Pn PFC response in the spleen of: (a) BALB/c mice (11), and 
(b)  nude mice  (0).  Each  point represents the mean  from a  cohort  of three  to  four mice with 
standard deviations (SD) indicated by the vertical bar. 
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Fla.  4.  The kinetics of Pn-specific PFC responses in the spleens of.. (a) BALB/c mice (I) and LM 
([ZI); and (b) nude mice (0). Each point represents the mean from a cohort of three to four mice 
with standard deviations (SD) indicated by the vertical bar. 
occurring on day 2-4, day  10-11, and day  14  (Fig. 2 b). This reciprocal out-of-phase 
relationship between the curves of Pn-specific PFC and T-15 binding is typical of the 
BALB/c anti-Pn immune response (4). 
In  contrast,  the  kinetics of splenic anti-Pn  production  in  thymus-deficient, nude 
mice immunized with  Pn  vaccine was not cyclical (Fig. 3 b).  Instead, a  first peak of 
specific PFC reached on  day 5  (445  +  170  PFC/106 splenocytes) was  followed by a 
decline and  then  a  plateau  during which  the  PFC  values ranged  between  25  _  13 
(day  10)  and  40  ±  15  (day  13).  No  significant  second  peak  of anti-Pn  response 
occurred. The control group of euthymic BALB/c mice displayed a  typical biphasic 
response (550 ±  160 PFC, day 5, and 225 ±  24 PFC, day 12)  (Fig. 3a). Similar results 
were  obtained  in  another  experiment  comparing  nude  mice  with  both  LM  and 
BALB/c mice (Fig. 4). The anti-Pn PFC responses of euthymic mice were essentially 
the same, with a  first peak on day 5-6 followed by a  decline to near background by 
day 10 and a  second peak again on day 12 (Fig. 4 a). Nude mice, however, responded 
by only one  round  of PFC  culminating on  day 5  (140  ±  20  PFC/106  splenocytes) 
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F=c. 5.  Anti-Pn antibody determined by passive HA in the serum of mice immunized with Pn 
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to four mice bled and killed on the indicated day after immunization: BALB/c ('), nude (O), LM 
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Fie. 6.  The kinetics of Pn-specific PFC responses in the spleens of.. (a) LM (C]) and TG-nude mice 
(A); (b) nude mice (O). Each point is the mean ± SD from a cohort of four mice. 
It should be noted that the circulating antibody response to Pn was indistinguish- 
able  between  BALB/c,  nude,  LM,  and  TG-nude  mice as  measured  by  Pn-specific 
passive  HA. Typically, the serum  anti-Pn  antibody titers  would  peak at  day 8  and 
thereafter decline.  By day  14, all mice showed significantly decreased levels (20-30% 
of maximum values) of Pn-specific serum antibody (Fig. 5). 
In all mice, the T-15 component of the anti-Pn response was dominant as measured 
by PFC inhibition.  Pooled cells of representative  BALB/c, nude, and LM mice were 
equally inhibited  (75-85%)  by a specific rabbit anti-T-15 serum. In cases where more 
than a  single anti-Pn  PFC peak occurred, both were predominantly T-15 positive. 
The experiments shown in Figs.  3 and 4 were repeated using euthymic LM, nude 
mice, and TG-nude. Again, the splenic anti-Pn PFC activity of LM mice was biphasic 
with an initial peak on day 5-6 (140 _  50 PFC/106 splenocytes) followed by a second 
peak on day  12 (80 +_ 20 PFC/106 splenocytes)  (Fig. 6 a). A  biphasic pattern was not 
apparent  in  nude  mice  (Fig.  6b).  In this  experiment,  nude  mice reached  an  initial 
anti-Pn peak on day 5  (180 +  30 PFC/106 splenocytes) that declined significantly by 
day 9. Anti-Pn values for day 9-14 ranged  from a  high of-~70  (day  10)  to a  low of 
230 (day 12).  No significant peak of anti-Pn activity occurred.  However, when nude 
mice were grafted with genetically compatible BALB/c thymus (TG-nude mice) and 
immunized  with  Pn,  the  distinctive  biphasic  kinetics  of PFC  production  returned, 
with  peaks  on  days  4  (280  +  40  PFC/106  splenocytes)  and  12  (75  +  35  PFC/106 
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Fxo.  7.  Relative changes in binding of ]25I-TEPC-15  by spleen cells during'the anti-Pn antibody 
response. Values are based upon the ratio of specific T-15 binding (Materials and Methods) between 
immunized and nonimmunized mice.  (a) BALB/c mice ([]), LM (i-q) and TG-nude mice (A); (b) 
nude mice, exp.  1 (O) and exp. 2 (O). 
The changes in T-15 binding by splenic lymphocytes also differed between normal 
and athymic mice. The data shown in Fig.  7 bear on the Pn response in Figs. 4 and 
6.  BALB/c,  LM,  and  TG-nude  mice  showed  patterns  of T-15  binding  that  were 
virtually identical (Fig.  7 a) and typical of the BALB/c anti-Pn immune response (4). 
Peaks of T-15 binding occurred at day 3-4 and day  10-11. These expansions are the 
reciprocal of the corresponding PFC kinetics. Conversely, T-15 binding in nude mice 
either declined and remained depressed (Fig. 7 b, exp.  1) or did not seem significantly 
affected by the ongoing anti-Pn  response (exp.  2).  The changes that did occur were 
not  in  phase  with  the  T-15  binding  oscillations  typical  of the thymus-associated 
BALB/c anti-Pn immune response. 
Discussion 
Our experiments demonstrate that  the repeated  (biphasic) appearance of anti-Pn 
antibody (IgM) PFC in mice immunized with a single injection of Pn vaccine depends 
on the presence of the thymus. Although Pn vaccine induces in nude mice an initial 
peak of T-15-bearing PFC and levels of circulating anti-Pn antibody indistinguishable 
from  that  occurring  in  normal  mice,  a  biphasic  PFC  response  is  absent.  Thymic 
reconstitution  restores the cyclical immune response. Thus, at least a  portion of the 
anti-Pn  response seems to be thymus-dependent.  Although  our experiments cannot 
rule out an effect of antibody that  is mediated by T  cells, it seems clear that serum 
antibody  does  not  affect  the  PFC  precursors  either  directly  or  via  competitive 
interactions with antigen in such a way as to produce a biphasic anti-Pn response. 
The immunization of BALB/c mice with Pn vaccine is accompanied by expansion 
or activation of cells binding the dominant idiotype, T-15, of the Pn-reactive B cells. 
Appropriate control experiments were performed to demonstrate that  the increased 
binding  of 12~I-TEPC-15  is  indeed  specific  for the  idiotopic  determinant  and  thus 
reflects  the  amount  of cell-associated T-15  receptors  (i.e.,  anti-idiotypic  cells).  The 
increased T-15-binding activity seen in BALB/c mice was completely absent  in  Pn- 
immunized nude mice. The latter could not be a result of a lack of idiotypic stimulus 
because the initial response of T-1f-positive, anti-Pn PFC in nude mice is equivalent 
to  that  in  either  BALB/c  or LM  mice.  Furthermore,  implantation  of a  thymus  in 
nude mice restores their ability to express the anti-idiotypic cellular activity. 
Thus it would seem that although a sufficient idiotypic stimulus is present in nude 
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component is anti-idiotypic T  cells. That both cyclical PFC production and the anti- 
idiotypic response are missing in thymusless mice strongly implies that  the cyclical 
nature of the anti-Pn  response is causally linked with the  reciprocal anti-idiotypic 
response. This is entirely consistent with the finding of Romball and Weigle (8) that 
T cell and not B cell mitogens are capable of abrogating the cyclical immune response. 
Cycling has been noted in various species with antigens ranging from haptens (16) 
to bacterial antigen  (2)  and  alloantigens  (17), and  in  both T-independent and  T- 
dependent antibody responses (2-8), as well as cell-mediated responses (18,  19). The 
cycling is independent of the immunization route and of the serum antibody levels 
(1-8). What is most remarkable is that the peaks of AFC appear almost exactly every 
6-10 d regardless of the antigen or animal species. This constancy leads us to believe 
that  the  cyclical immune  response  is  the  expression  of a  fundamental  cybernetic 
system for immunological regulation. Viewed in this light, our data appear to be a 
significant demonstration of the idiotype-specific, regulatory equilibrium originally 
postulated by Jerne (20-22). 
Numerous studies have demonstrated that the capacity for idiotype-specific immune 
regulation exists (23-29) most often by demonstrating idiotype-specific help, suppres- 
sion, or activation. Our data are similar in that we demonstrate that specific activation 
of the anti-T-15 clone(s) occurs during the BALB/c anti-Pn immune response. More 
importantly,  our  data  indicate  that  the  interaction  between  idiotypic  and  anti- 
idiotypic clones is thymus-dependent, mutually reciprocal, and continuing. There is 
no reason to expect that this cycling ends after 14 d. Indeed, cyclical AFC production 
has been shown to occur for at least 50 d  (30)  and regularly periodic fluctuation in 
antibody production has been measured over a period of years (31). The longevity of 
these cyclical phenomena seemingly preclude a role for exogenous antigen. Instead, it 
is likely that the basis for continuing immune periodicity is entirely internal. 
Recently,  Eichmann  et  al.  (32)  have  demonstrated  that  under  the  appropriate 
conditions, anti-idiotypic T-helper cells can induce B-memory cells to become AFC, 
even in the absence of antigen. It is conceivable that periodic waves of anti-idiotypic 
helper cell activity could give rise to the long-lived cyclical immune response. The 
cyclical immune response then, may be visualized as a dynamic regulatory equilibrium 
that continuously balances idiotypic and anti-idiotypic cell populations via positive 
and negative regulatory interactions. 
The effectors of this regulation appear to be T  cells. Thus,  the cyclical immune 
response is thymus-dependent. However, since Pn  is a  T-independent antigen,  it  is 
likely that  both T  and  B  cells may  induce  those  regulatory events  leading to the 
cyclical immune response. That primed B cells do have the capacity to induce T-cell- 
mediated suppression has been demonstrated in other systems (33). 
Finally, as it is known that the cyclical immune response may be abrogated by the 
administration of passive specific antibody (30), the concept of anti-idiotypic regula- 
tion  may complement  previously  proposed  mechanisms  of immune  regulation,  in 
particular the  antibody feedback effect. Even  in  those situations  where the steady 
level of circulating antibody ostensibly bears no relationship to the cycling appearance 
of idiotypic or  anti-idiotypic cells  (4,  8,  and  this  paper),  significant  cell-antibody 
interactions might  still occur in  situ.  Indeed, preliminary results indicate that  T-15 
binding  increases  after mild  trypsinization  and  subsequent  in  vitro  incubation  of 
splenocytes from Pn-immunized BALB/c mice (G. Kelsoe and J. Cerny. Unpublished 
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Summary 
The role of the thymus in the cyclical appearance of the dominant idiotype of the 
myeloma protein  secreted  by  the  TEPC-15  plasmacytoma  (T-15)-bearing  plaque- 
forming cells (PFC)  and anti-idiotypic cells (i.e.,  cells with receptors for T-15) in the 
spleen during a primary response to the phosphorylcholine determinant of Streptococcus 
pneumoniae,  strain  R36a  (Pn)  was studied  using normal mice, thymus-deficient nude 
mice,  and  thymus  gland-grafted  nude  mice  (TG-nude).  The  nude  mice  and  their 
phenotypically normal  littermates  (LM)  were  backcrossed on  the  BALB/c  genetic 
background. 
The kinetics of the anti-Pn  PFC  response of BALB/c inbred  mice, littermates of 
nude mice, and TG-nude mice were essentially the same. There was an initial peak 
on day 5-6 followed by a decline to near background, and then a second peak on day 
12. In nude mice, the first peak ofanti-Pn PFC (day 5) was comparable in magnitude 
to that of mice with an intact thymus; however, there was no second peak. In contrast 
to the cellular response measured at the level of PFC, the serum antibody response to 
Pn  (assayed  by  passive  hemagglutination  of  sheep  erythrocytes  coated  with  Pn 
polysaccharide) was comparable in all groups of mice and did not show a measurable 
oscillation. 
The anti-idiotypic cellular activity was determined by the ability of spleen cells to 
bind radiolabeled (125I) TEPC-15 myeloma protein (IgA, •)  which carries an idiotypic 
determinant indistinguishable from that of most anti-phosphorylcholine antibodies in 
BALB/c mice. Binding of radiolabeled McPC-603  (IgA, K) and MOPC-315  (IgA, A2) 
myeloma proteins (which lack the T-15 idiotypic determinant) served as controls, The 
changes  in  T-15  binding  by  splenic  lymphocytes  following  the  Pn  immunization 
differed between normal and athymic mice. BALB/c, LM, and TG-nude mice showed 
a biphasic pattern with peaks at days 3-4 and  10-11 that was nearly reciprocal to the 
PFC  curve.  On  the  other  hand,  T-15  binding  in  nude  mice  either  declined  and 
remained depressed or was not affected by the ongoing anti-Pn response. 
These  observations  demonstrate  that  mature  T  cells  are  required  for  cyclical 
idiotypic and anti-idiotypic responses to immunization with a T-independent antigen 
and suggest that the cyclical immune response may result from an interaction between 
idiotypic and anti-idiotypic cell clones. 
Received  for publication 23July  1979 and in revised  form  16 October 1979. 
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